Role of Growth Hormone in Breast Cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Endocrinology

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2016-1928PMID 28379395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mammary Gland Development

  2017cited by this paper
• Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production

  2017cited by this paper
• The association between body mass index and immunohistochemical subtypes in breast cancer.

  2017cited by this paper
• Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression

  2016cited by this paper
• Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo - Meta-analyses on efficacy and adverse events based on randomized clinical trials.

  2016cited by this paper
• Association study between growth hormone receptor (GHR ) gene polymorphisms and obesity in Korean population

  2016cited by this paper
• Novel Functional Role of NK3R Expression in the Potentiating Effects on Somatolactin α Autoregulation in grass carp pituitary cells

  2016cited by this paper
• Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 Update.

  2016cited by this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and cancer: an old debate revisited.

  2016cited by this paper
• Epithelial-Mesenchymal Transition and Breast Cancer

  2016cited by this paper
• Resistance to Targeted Therapies in Breast Cancer.

  2016cited by this paper
• Risk of malignant neoplasms in acromegaly: a case–control study

  2016cited by this paper
• Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer

  2016cited by this paper
• Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer1

  2016cited by this paper
• Mammary gland development--It's not just about estrogen.

  2016cited by this paper
• Acromegaly and cancer: an old debate revisited

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Dopamine inhibits somatolactin gene expression in tilapia pituitary cells through the dopamine D2 receptors.

  2016cited by this paper
• EMT in Breast Carcinoma—A Review

  2016cited by this paper
• Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?

  2016cited by this paper
• Identification of signaling pathways associated with cancer protection in Laron syndrome.

  2016cited by this paper
• Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women

  2016cited by this paper
• A positive feedback loop between prolactin and STAT5 promotes angiogenesis.

  2015cited by this paper
• Indications for Prognostic Gene Expression Profiling in Early Breast Cancer

  2015cited by this paper
• Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer*

  2015cited by this paper
• New Findings on Breast Cancer Stem Cells: A Review

  2015cited by this paper
• Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

  2015cited by this paper
• Oncogenic somatic events in tissue-specific stem cells: a role in cancer recurrence?

  2014cited by this paper
• Birth weight and adult cancer incidence: large prospective study and meta-analysis

  2014cited by this paper
• Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization.

  2014cited by this paper
• New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

  2014cited by this paper
• Placental Lactogen Is Expressed but Is Not Translated into Protein in Breast Cancer

  2014cited by this paper
• Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells

  2014cited by this paper
• Localization and expression patterns of prolactin-like protein J in mouse testis.

  2014cited by this paper
• Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance.

  2014cited by this paper
• Somatostatin receptors: from signaling to clinical practice.

  2013cited by this paper
• Proliferin-related protein overexpression in SGC‑7901 gastric cancer cells inhibits in vitro cell growth and tumorigenesis in nude mice.

  2013cited by this paper
• Invasive cancers are not necessarily from preformed in situ tumours — an alternative way of carcinogenesis from misplaced stem cells

  2013cited by this paper
• Growth hormone and cancer: an update on progress

  2013cited by this paper
• The role of prolactin receptor in GH signaling in breast cancer cells.

  2013cited by this paper
• Systematic Reviews and Meta-and Pooled Analyses Growth Hormone Receptor Polymorphism and Growth Hormone Therapy Response in Children : A Bayesian Meta-Analysis

  2012cited by this paper
• The tumor microenvironment.

  2012cited by this paper
• CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity

  2012cited by this paper
• Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.

  2012cited by this paper
• Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression.

  2012cited by this paper
• Growth hormone and cell growth.

  2012cited by this paper
• The current state of breast cancer classification.

  2012cited by this paper
• Mammary gland development

  2012cited by this paper
• Estrogen and Progesterone in Normal Mammary Gland Development and in Cancer

  2011cited by this paper
• Angiogenesis Induced by Signal Transducer and Activator of Transcription 5A (STAT5A) Is Dependent on Autocrine Activity of Proliferin*

  2011cited by this paper
• Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.

  2011cited by this paper
• Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C.

  2011cited by this paper
• Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk

  2011cited by this paper
• Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study

  2011cited by this paper
• Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer.

  2010cited by this paper
• Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

  2009cited by this paper
• Growth hormone excess promotes breast cancer chemoresistance.

  2009cited by this paper
• New mechanisms for PRLr action in breast cancer.

  2009cited by this paper
• Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.

  2009cited by this paper
• Epithelial to mesenchymal transition and breast cancer

  2009cited by this paper
• Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

  2008cited by this paper
• The Contribution of Growth Hormone to Mammary Neoplasia

  2008cited by this paper
• DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells

  2008cited by this paper
• Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis

  2008cited by this paper
• Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

  2008cited by this paper
• Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies

  2008cited by this paper
• Advanced rat mammary cancers are growth hormone dependent.

  2007cited by this paper
• Anthropometric factors and risk of melanoma in women: A pooled analysis

  2007cited by this paper
• The rapid activation of protein synthesis by growth hormone requires signaling through mTOR.

  2007cited by this paper
• Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy

  2007cited by this paper
• Targeting the tumor microenvironment.

  2007cited by this paper
• AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone.

  2007cited by this paper
• Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report.

  2007cited by this paper
• The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development

  2007cited by this paper
• Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction.

  2007cited by this paper
• Mammary stem cell number as a determinate of breast cancer risk

  2007cited by this paper
• Co‐twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins

  2007cited by this paper
• Defects in growth hormone receptor signaling.

  2007cited by this paper
• Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis

  2007cited by this paper
• αCP1 Mediates Stabilization of hTERT mRNA by Autocrine Human Growth Hormone*

  2007cited by this paper
• Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.

  2007cited by this paper
• Growth hormone receptor polymorphisms.

  2007cited by this paper
• Does growth hormone cause cancer?

  2006cited by this paper
• Role of birthweight in the etiology of breast cancer

  2006cited by this paper
• Growth patterns and the risk of breast cancer in women.

  2006cited by this paper
• Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).

  2006cited by this paper
• Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study.

  2006cited by this paper
• The oncogenic potential of growth hormone.

  2006cited by this paper
• Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.

  2006cited by this paper
• The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth

  2006cited by this paper
• Autocrine growth hormone prevents lactogenic differentiation of mouse mammary epithelial cells.

  2006cited by this paper
• p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis

  2005cited by this paper
• Key stages in mammary gland development: The cues that regulate ductal branching morphogenesis

  2005cited by this paper
• Medaka Receptors for Somatolactin and Growth Hormone: Phylogenetic Paradox Among Fish Growth Hormone Receptors

  2005cited by this paper
• Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.

  2005cited by this paper
• The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.

  2005cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005cited by this paper
• Gene Expression Profiling to Identify Oncogenic Determinants of Autocrine Human Growth Hormone in Human Mammary Carcinoma*

  2005cited by this paper
• Angiogenesis of breast cancer.

  2005cited by this paper
• Breast cancer in young women.

  2005cited by this paper

• The role of growth hormone in metastasis and angiogenesis of breast cancer.

  2026cites this paper
• Growth Hormone, Not Simply Just a Hormone for Growth.

  2026cites this paper
• Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.

  2026cites this paper
• Structural insights and bioactivity of silver(I) triazole complexes with selective anticancer and broad-spectrum antimicrobial effects

  2026cites this paper
• The epidemiology of mammary tumours in insured female dogs in Sweden.

  2025cites this paper
• DriverMEDS: cancer driver gene identification using mutual exclusivity from embeded features and driver mutation scoring.

  2025cites this paper
• STsisal: a reference-free deconvolution pipeline for spatial transcriptomics data

  2025cites this paper
• Growth Hormone Signaling in Bladder Cancer: Transcriptomic Profiling of Patient Samples and In Vitro Evidence of Therapy Resistance via ABC Transporters and EMT Activation

  2025cites this paper
• Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2.

  2024cites this paper
• A role for JAK2 in mediating cell surface GHR-PRLR interaction

  2024cites this paper
• Growth Hormone Action as a Target in Cancer: Significance, Mechanisms and Possible Therapies.

  2024cites this paper
• Prediction of Prognosis and Immunotherapy Response of Gastric Cancer Based on Glutamine Metabolism-Related Genes.

  2024cites this paper
• Nutrition, GH/IGF-I signaling, and cancer.

  2024cites this paper
• Prognostic significance of expression of signal molecules to evaluate the metastasis of carcinoma of various locations

  2024cites this paper
• Excess endocrine growth hormone in acromegaly promotes the aggressiveness and metastasis of triple-negative breast cancer

  2024cites this paper
• Application of BODIPY in photodynamic therapy

  2024cites this paper
• Simultaneous Detection of Prolactin and Growth Hormone Using a Dual-label Time-resolved Fluorescence Immunoassay

  2024cites this paper
• A statistical learning method for simultaneous copy number estimation and subclone clustering with single-cell sequencing data

  2024cites this paper
• Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development

  2024cites this paper
• Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas

  2023cites this paper
• WIP1 is a novel specific target for growth hormone action

  2023cites this paper
• Seroprevalence of Toxoplasma gondii infection among patients of a tertiary hospital in Guangzhou, Guangdong province, PR China

  2023cites this paper
• Quercetin Suppresses TNBC Cell by Targeting ORM2

  2023cites this paper
• Genetic and lifestyle factors for breast cancer risk assessment in Southeast China

  2023cites this paper
• Early investigations of 20-kDa human placental GH show promise.

  2023cites this paper
• A statistical learning method for simultaneous copy number estimation and subclone clustering with single cell sequencing data

  2023cites this paper
• Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a

  2023cites this paper
• Applied Physiology of Breast Cancer

  2022cites this paper
• Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

  2022cites this paper
• Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway

  2022cites this paper
• Hormone supply to the pituitary gland: A comprehensive investigation of female-related tumors (Review)

  2022cites this paper
• Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development (carcino-evo-devo)

  2022cites this paper
• Ultrasound targeted microbubble destruction-mediated SOCS3 attenuates biological characteristics and epithelial-mesenchymal transition (EMT) of breast cancer stem cells

  2022cites this paper
• Body Shape Phenotypes and Breast Cancer Risk: A Mendelian Randomization Analysis

  2022cites this paper
• Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer

  2022cites this paper
• Drug Repurposing by Tumor Tissue Editing

  2022cites this paper
• Morphological and molecular effects of overexpressed GH on mice mammary gland.

  2021cites this paper
• Mammary Tumors Growing in the Absence of Growth Hormone are More Sensitive to Doxorubicin than Wild-type Tumors.

  2021cites this paper
• GHR is involved in gastric cell growth and apoptosis via PI3K/AKT signalling

  2021cites this paper
• Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer

  2021cites this paper
• Exposure to endocrine disruptors and risk of breast cancer: a systematic review.

  2021cites this paper
• The history, physiology and treatment safety of growth hormone

  2021cites this paper
• ROLE OF SEX HORMONES IN MODULATING BREAST AND OVARIAN CANCER ASSOCIATED PAIN.

  2021cites this paper
• Roles of ncRNAs as ceRNAs in Gastric Cancer

  2021cites this paper
• Pharmacological effects of Picrasma quassioides (D. Don) Benn for inflammation, cancer and neuroprotection (Review)

  2021cites this paper
• Ponatinib miRNA ifadelerini düzenleyerek meme kanseri hücrelerini hedefler

  2021cites this paper
• Human Breast Extracellular Matrix Microstructures and Protein Hydrogel 3D Cultures of Mammary Epithelial Cells

  2021cites this paper
• Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer

  2021cites this paper
• Postmenopausal dense breasts maintain premenopausal levels of GH and insulin-like growth factor binding proteins in vivo.

  2020cites this paper
• Growth Hormone Receptor Regulation in Cancer and Chronic Diseases

  2020cites this paper
• Inferences from dysregulated long non-coding RNA-mediated competing endogenous RNAs in various chemotherapy drugs and evaluation of drug response in breast cancer

  2020cites this paper
• Pets as Sentinels, Forecasters and Promoters of Human Health

  2020cites this paper
• Regulation of the JAK2-STAT5 Pathway by Signaling Molecules in the Mammary Gland

  2020cites this paper
• Patterns of de-novo metastasis and breast cancer-specific mortality by race and molecular subtype in the SEER population-based dataset

  2020cites this paper
• Characterization of growth hormone (GH) in Chinese soft-shelled turtle: Molecular identification, capability in activating GH receptor and tissue distribution

  2020cites this paper
• GHR knockdown enhances the sensitivity of HCC cells to sorafenib

  2020cites this paper
• Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors

  2020cites this paper
• Genetic Code Expansion Enables Site-Specific PEGylation of a Human Growth Hormone Receptor Antagonist through Click Chemistry.

  2020cites this paper
• The effects of 20-kDa human placental GH in male and female GH deficient mice: an improved human GH?

  2020cites this paper
• Connection between SOX7 Expression and Breast Cancer Prognosis

  2020cites this paper
• Common pathways and functional profiles reveal underlying patterns in Breast, Kidney and Lung cancers

  2020cites this paper
• DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations

  2020cites this paper
• Development of transplantable mouse models to assess the role of prolactin inducible protein in breast tumorigenesis

  2019influential citation
• Canine and Feline Spontaneous Mammary Tumours as Models of Human Breast Cancer

  2019cites this paper
• Genetic links between endometriosis and cancers in women

  2019cites this paper
• Metabolic effects and long-term safety of childhood growth hormone treatment

  2019cites this paper
• Idiopathic gigantomastia: newer mechanistic insights implicating the paracrine milieu

  2019cites this paper
• Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer

  2019cites this paper
• Detection of early breast cancer beyond mammographic screening: a promising biomarker panel.

  2019cites this paper
• Der Tumormarker Prolaktin

  2019cites this paper
• The effects of growth hormone on therapy resistance in cancer

  2019cites this paper
• Breast Cancer Risk Factors

  2019cites this paper
• Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2

  2019cites this paper
• Acetylcholine Modulates the Hormones of the Growth Hormone/Insulinlike Growth Factor-1 Axis During Development in Mice

  2018cites this paper
• Growth Hormone's Links to Cancer.

  2018cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?

  2018cites this paper
• Fetal Estetrol (E4) Inhibits Growth Hormone (GH) Signal Transduction in Breast Cancer Cell Lines

  2018cites this paper
• Autocrine Growth Hormone Mediated Curcumin Resistance Overcame by Autophagy Inhibition via Bafilomycin in MDA-MB-231 and T47D Breast Cancer Cells

  2018cites this paper
• Induction of Cisplatin Resistance by Hormones in Breast Cancer

  2017cites this paper
• The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies

  2017cites this paper
• Growth Hormone and the Epithelial-to-Mesenchymal Transition

  2017cites this paper